Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic
NCT ID: NCT04451798
Last Updated: 2022-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2016-12-31
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impella in Cardiogenic Shock Registry
NCT06007963
Sub-threshold Pacing to Prevent Pacemaker-induced Ventricular Tachycardia
NCT01906775
Comparison of Multi-point Pacing and Conventional CRT Through Non-invasive Hemodynamics Measurement and Global Longitudinal Strain Assessment
NCT04299360
Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
NCT02279979
Central Haemodynamics and Pacing for AV Block
NCT07276490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Impella implantation and hemodynamic measurement
Impella CP microaxial pump
ramp test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Impella CP microaxial pump
ramp test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with
* signs of left heart failure and pulmonary congestion
* and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l
16 Years
91 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jena University Hospital
OTHER
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sven Möbius-Winkler
Principal Investigator, Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven Möbius-Winkler, MD
Role: PRINCIPAL_INVESTIGATOR
Universityhospital Jena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Jena
Jena, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMW 07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.